Two human term placentas have been perfused in situ with cholesterol-7a-3H.
It is suggested that the human placenta has the capacity to utilize circulating cholesterol at this stage of steroid biogenesis.
Biosynthetic
pathways in most steroid producing organs have been found to involve the conversion of cholesterol to the various steroid hormones characteristic of that organ. In the placenta, the cholesterol so utilized has been found to be derived from a series of precursors including acetate, mevalonate, squalene, and lanosterol (1, 2) . Placental conversion of cholesterol to pregnenolone2) and progesterone in -vitro has been demonstrated (3) (4) (5) . However, in vitro --studies demonstrate the capacity for a reaction to occur, without necessarily reflecting the situation extant in vivo. Further, the relative contribution
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of circulating precursors as opposed to de novo _-placental synthesis at these stages of steroid biogenesis remains to be ascertained. The present study was devised in an effort to assess the capacity of the human term placenta to utilize circulating cholesterol in steroid biogenesis in vivo, and to ascertain the amount of circulating cholesterol available to the placenta from both the maternal and fetal compartments.
METHODS AND MATERIALS
Perfusion Technique: Studies were carried out on two patients scheduled for elective repeat cesarean section and tubal ligation at term with no other medical or obstetric complications of the present pregnancy.
These studies were performed in a manner similar to that previously reported from this laboratory for the placental perfusion of labeled pregnenolone (6) . In brief, after catheterization of an umbilical artery and the umbilical vein, whole blood was perfused via the umbilical arterial catheter, and the venous effluent collected in ethanol.
A 50 percent (v/v) ethanolic solution of cholesterol-7a-3H (0.8 ml.) was injected into the umbilical arterial catheter at one minute intervals, over a period of seven minutes, followed by an additional two minute perfusion with blood only.
At the conclusion of the procedure, the placenta was manually separated from the uterus, its membranes and cord dissected free, and the placenta was then homogenized in 80% ethanol.
Materials:
All organic solvents were redistilled prior to use.
Crystalline steroid standards were recrystallized prior to use and corrected melting points determined.
Cholesterol-7cx-3H, Lot. No. 184-32-323) with a 
Extraction and Purification:
This was carried out as described previously (6) . Briefly, placenta and venous effluent were extracted repeatedly with 80% and absolute ethanol.
This was followed by acetone extraction and methanol precipitation at -170~. A dichloromethane-water partition was then employed in a counter-current fashion, using 6 lower phase transfers, and the dichloromethane fraction further analyzed.
An outline of the procedures employed in the analysis of the dichloromethane fraction is illustrated in Figure 1 . Twenty-four hour urine specimens were collected for three days following the procedure, and aliquots of each days urine assessed for their radioactive content.
Countercurrent
Distribution (CCD): Twenty-four transfer distributions were carried out in a manual Craig-Post apparatus using the following solvent systems:
No.
1.
Cyclohexane, ethyl acetate, ethanol, water (7:3:5:5).
2. Petroleum ether, methanol, water (10:7:3).
3. Cyclohexane, ethanol, water (10:9:1).
4. n-Hexane, ethanol, water (10:4.8:5.2).
5. Cyclohexane, ethyl acetate, ethanol, water (4:1:3:2) Derivative formation: Acetylation was carried out with acetic anhydride in anhydrous pyridine (1:2) at room temperature overnight. Enzymatic deacetylation using the enzyme, Acylase5) was performed in the following manner: the dried steroid extract was dissolved in a drop of ethanol and 1.0 ml. of a 0.1 Molar pH 7.3 phosphate buffer.
Three mg of the enzyme, dissolved in 0.5 ml of the buffer were then added, and the solution incubated at 370C for 4 hours.
The reaction was stopped by the addition of water.
Thin Layer Chromatoqraphy (TLC): Slurries of silica gel G4) were applied to glass plates (5 x 20 cm or 20 x 20 cm) and activated at 12OOC. Ascending chromatography in the following solvent systems was employed:
Chloroform, acetone (19:l).
2. Benzene, chloroform (1:l).
3. Ethyl Acetate, chloroform (5O:l).
For detection of radioactivity on the 5 x 20 cm plates, a Packard Model 7201 radiochromatogram scanner was used.
Estimation of C-21 Steroids:
Progesterone was measured in ethanol by ultraviolet absorption at 240 rnv using the Allen correction formula (7). For detection of pregnenolone on thin-layer chromatograms either a phosphomolybdic acid or water spray was employed.
Progesterone was detected on thin layer chromatograms with ultraviolet light. Measurement of 3p-hydroxy-A5 steroids was carried out as described by Oertel and Eik-Nes (8).
Cholesterol Determinations:
Total and esterified cholesterol were measured in serum utilizing the methods described by Connerty et al. (9, 10).
Recrystallization
to Constant Specific Activity: Crystalline pregnenolone acetate was added to part of the isolated radioactive material obtained from the third CCD.
Successive recrystallizations from three different solvent systems were performed.
The carrier was estimated gravimetrically.
Countinq Procedure:
Counting was carried out in an automated two channel Packard Tri-Carb liquid scintillation counter (series 3000). The tritium window was set from 10 to 100% of the analyzer full scale with a relative gain of 60, and the carbon window was set from 10 to 70% of full scale with a relative gain of 5. Samples were counted in 10 ml toluene containing 3.0 g/l PPO (2,5-diphenyloxazole) and 100 mg/l POPOP (1, 4-bis-2-(4-methyl-5-phenyloxazolyl) benzene).
Urine samples (0.5 ml) were first dissolved in one ml methanol and then 10 ml of the above toluene scintillant solution added. Appropriate quench corrections were made using an internal standard technique.
Counting efficiencies were monitored utilizing standards prepared in the same manner as the samples. 
DISCUSSION
It is becoming increasingly apparent that bloodborne precursors, reaching the placenta from the maternal and/or fetal compartments may be utilized in the placental elaboration of certain estrogens (11-15).
That circulating precursors, at least from the fetal compartment, are necessary for the placental production of progesterone seems less certain for reasons detailed in earlier communications (6, 16 (27) . This increase is present in both the free and esterified fractions.
The values obtained in this study are somewhat lower than those found by de Alvarez et al. (27) . Sample size in the present study was small, and it is known that there is wide variation in maternal cholesterol levels.
Circulating cholesteryl sulfate has been found in human plasma (28) and umbilical cord blood (29) .
Whether it is utilized in placental steroidogenesis remains to be ascertained. 
